Sonographic Analysis of Nails in Psoriatic Arthritis and Healthy Controls
NCT04718428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2021-01-26
Summary
This study aims to identify the nail ultrasonography (NUSG) properties in patients with psoriatic arthritis (PsA) and healthy controls by a participant-based evaluation; to assess feasibility, reliability, and discriminative performances; to explore final scorings; and to determine associations between the NUSG scores and participant characteristics, including demographics and disease-related factors.
Conditions
- Psoriatic Arthritis
- Psoriatic Nail
Interventions
- DIAGNOSTIC_TEST
-
Nail Ultrasonography
The MyLab 60 (Esaote Biomedica Genoa, Italy) device and linear probe were used. Nails were examined in B-mode grayscale and power Doppler.
Sponsors & Collaborators
-
Marmara University
lead OTHER
Principal Investigators
-
Mehmet Tuncay Duruöz, Professor · Marmara University
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-14
- Primary Completion
- 2019-06-15
- Completion
- 2020-08-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
NCT01172938 ·Status: COMPLETED ·Phase: PHASE3
-
Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients With Atypical Form of Psoriasis
NCT02899429 ·Status: COMPLETED
-
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
NCT04929210 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)
NCT02028169 ·Status: COMPLETED
-
The Disease Severity In Patients With Psoriasis
NCT05943405 ·Status: COMPLETED
-
An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis
NCT00723528 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment
NCT04908189 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
NCT01077362 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Psoriatic Arthritis
NCT00001420 ·Status: COMPLETED
-
Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment
NCT04632927 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study
NCT05925842 ·Status: UNKNOWN
-
Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
NCT05835843 ·Status: COMPLETED
-
Psoriasis Longitudinal Assessment and Registry
NCT00508547 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
NCT04908202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris
NCT06654817 ·Status: COMPLETED
-
Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information
NCT06790940 ·Status: NOT_YET_RECRUITING
-
The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)
NCT02693470 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)
NCT01276847 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis
NCT05640245 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab
NCT03336281 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
NCT02016482 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)
NCT03881059 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis
NCT05124080 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
NCT03104400 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis
NCT05153148 ·Status: COMPLETED ·Phase: PHASE2